AI assistant
Sending…
Glenmark Pharmaceuticals ltd — Audit Report / Information 2020
Dec 11, 2019
62608_rns_2019-12-11_53f5fdfa-72bd-4104-bfc2-ede476086c31.pdf
Audit Report / Information
Open in viewerOpens in your device viewer
==> picture [65 x 34] intentionally omitted <==
| Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: | Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: | Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: | Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: |
|---|---|---|---|
| Related parties withwhomtheGrouphastransacted during the period | |||
| KeyManagementPersonnel | |||
| Mr. Glenn Saldanha (Chairman&Managing Director) | |||
| Mrs. Cherylann Pinto (Executive Director) | |||
| Mr. VS Mani (Executive Director&Global Chief Financial Officer) | |||
| Mr.RajeshDesai(Non-executive Director) | |||
| Mr. Harish Kuber (Company Secretary & ComplianceOfficer) | |||
| Mrs.B.E.Saldanha (Non-executive Director) | |||
| Mr. D.R.Mehta (Non-executive Director) | |||
| Mr. Bernard Munos (Non-executive Director) | |||
| Mr.J.F.Ribeiro (Non-executive Director) | |||
| Dr.Brian W. Tempest (Non-executive Director) | |||
| Mr. Sridhar Gorthi (Non-executive Director) | |||
| Mr. Milind Sarwate (Non-executive Director) | |||
| Ms.SonaSairaRamasastry (Non-executive Directorwitheffect from 1 April 2019) | |||
| Enterprises over which significant influence exercised by key management personnel/directors | |||
| Glenmark Foundation | |||
| Glenmark Aquatic Foundation | |||
| Trilegal | |||
| Rs·in | million | ||
| NatureofTransaction | Asat | ||
| 30September2019 | |||
| Expenditure incurred forCSRactivities to | |||
| Glenmark Foundation | 65.23 | ||
| Glenmark Aquatic Foundation | 47.15 | ||
| Transactions with keymanagementpersonnel | |||
| Remuneration | |||
| - Mrs. Cherylann Pirito | 19.11 | ||
| -MrVS Mani | 30.58 | ||
| -Mr. Harish Kuber | 2.29 | ||
| Sitting fees paidtoNon-executive Directors | 4.2 | ||
| Asat | |||
| Related party balances | 30September2019 | ||
| Rsinmillion | |||
| (Payable)/ Advance given | |||
| Glenmark Foundation | (1.00) |
==> picture [74 x 75] intentionally omitted <==
More from Glenmark Pharmaceuticals ltd
Investor Presentation
2026
May 29
Investor Presentation
2026
May 29
Earnings Release
2026
May 29
Earnings Release
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 29
Board/Management Information
2026
May 29
Interim / Quarterly Report
2026
May 29